ÂÜÀòÂÒÂ×

Linda Genen, MD, MPH has an extensive work experience in the healthcare industry. Linda is currently serving as the Chief Medical Officer at ProgenyHealth, LLC since August 2020. In addition, they are also on the Board of Directors at Hera Health since October 2020.

Dr. Genen is a Distinguished Stanford Master of Science in Clinical Informatics Management (MCiM) Program Mentor at Stanford University School of Medicine since January 2021. This program aims to prepare working professionals to leverage digital innovations for delivering high-quality and cost-effective healthcare.

Linda is an investing member of Portfolia, participating in Portfolia Funds such as the FemTech Fund II and Active Aging & Longevity Fund. As a Portfolia Investor, they engage in up to 20 entrepreneurial company investments, pitch calls, and due diligence teams, particularly focusing on companies led by women and/or with diverse teams of founders.

Dr. Genen is also a leader and member of the Diversity, Equity, and Inclusion Committee at Women Business Leaders of the US Health Care Industry Foundation (WBL) since January 2022. WBL is a national nonprofit organization that convenes senior executive women from various healthcare sectors.

Previously, they held positions as an Assistant Professor at Hofstra North Shore-LIJ School of Medicine and as an Attending Neonatologist at Cohen Children's Medical Center, both roles starting in August 2010.

Dr. Genen was a Senior Vice President and Chief Medical Officer at UnitedHealth Group from December 2019 to August 2020. Before that, they contributed as the Chief Medical Officer - Women's Health and Senior National Medical Director at Optum from 2013 to 2019.

In 2022, they temporarily served as the Interim Head of Medical Affairs at Infinant Health from May to September.

Overall, Linda Genen, MD, MPH has a diverse background in healthcare leadership, clinical practice, medical informatics, and venture investments.

Linda Genen, MD, MPH has a diverse education background. Linda holds a Bachelor of Arts (BA) degree in Chemistry from Wellesley College. Linda then pursued a medical degree (MD) from the State University of New York Health Science Center at Brooklyn. Following that, they enrolled in the Executive Education Program at the Stanford University Graduate School of Business. Linda furthered their education in the field of Epidemiology by completing a Master of Public Health (MPH) degree at the Yale University School of Medicine. Additionally, Linda expanded their knowledge by studying Introduction to Digital Health and Strategy: Leveraging Emerging Technologies in Healthcare at the Columbia Business School.